OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Advances in histone demethylase KDM4 as cancer therapeutic targets
Dong Hoon Lee, Go Woon Kim, Yu Hyun Jeon, et al.
The FASEB Journal (2020) Vol. 34, Iss. 3, pp. 3461-3484
Open Access | Times Cited: 112
Dong Hoon Lee, Go Woon Kim, Yu Hyun Jeon, et al.
The FASEB Journal (2020) Vol. 34, Iss. 3, pp. 3461-3484
Open Access | Times Cited: 112
Showing 1-25 of 112 citing articles:
Benzimidazole and its derivatives as cancer therapeutics: The potential role from traditional to precision medicine
Yeuan Ting Lee, Yi Jer Tan, Chern Ein Oon
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 2, pp. 478-497
Open Access | Times Cited: 124
Yeuan Ting Lee, Yi Jer Tan, Chern Ein Oon
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 2, pp. 478-497
Open Access | Times Cited: 124
Tumor hypoxia: From basic knowledge to therapeutic implications
Chengheng Liao, Xijuan Liu, Cheng Zhang, et al.
Seminars in Cancer Biology (2023) Vol. 88, pp. 172-186
Open Access | Times Cited: 88
Chengheng Liao, Xijuan Liu, Cheng Zhang, et al.
Seminars in Cancer Biology (2023) Vol. 88, pp. 172-186
Open Access | Times Cited: 88
Epigenetics-targeted drugs: current paradigms and future challenges
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 25
Wanlin Dai, Xinbo Qiao, Yuanyuan Fang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 25
Proteomic and phosphoproteomic landscapes of acute myeloid leukemia
Michael H. Kramer, Qiang Zhang, Robert W. Sprung, et al.
Blood (2022) Vol. 140, Iss. 13, pp. 1533-1548
Open Access | Times Cited: 62
Michael H. Kramer, Qiang Zhang, Robert W. Sprung, et al.
Blood (2022) Vol. 140, Iss. 13, pp. 1533-1548
Open Access | Times Cited: 62
RETRACTED ARTICLE: KDM4 orchestrates epigenomic remodeling of senescent cells and potentiates the senescence-associated secretory phenotype
Boyi Zhang, Qilai Long, Shanshan Wu, et al.
Nature Aging (2021) Vol. 1, Iss. 5, pp. 454-472
Open Access | Times Cited: 57
Boyi Zhang, Qilai Long, Shanshan Wu, et al.
Nature Aging (2021) Vol. 1, Iss. 5, pp. 454-472
Open Access | Times Cited: 57
Advances in Histone Demethylase KDM3A as a Cancer Therapeutic Target
Jung Yoo, Yu Hyun Jeon, Ha Young Cho, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1098-1098
Open Access | Times Cited: 62
Jung Yoo, Yu Hyun Jeon, Ha Young Cho, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1098-1098
Open Access | Times Cited: 62
Genomic instability and metabolism in cancer
Haojian Li, Susan E. Zimmerman, Urbain Weyemi
International review of cell and molecular biology (2021), pp. 241-265
Closed Access | Times Cited: 46
Haojian Li, Susan E. Zimmerman, Urbain Weyemi
International review of cell and molecular biology (2021), pp. 241-265
Closed Access | Times Cited: 46
Development of EphA2 siRNA-loaded lipid nanoparticles and combination with a small‐molecule histone demethylase inhibitor in prostate cancer cells and tumor spheroids
Ezgi Öner, Mustafa Kotmakçı, Anne‐Marie Baird, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 41
Ezgi Öner, Mustafa Kotmakçı, Anne‐Marie Baird, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 41
SETD2: from chromatin modifier to multipronged regulator of the genome and beyond
Thom M. Molenaar, Fred van Leeuwen
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 6
Open Access | Times Cited: 32
Thom M. Molenaar, Fred van Leeuwen
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 6
Open Access | Times Cited: 32
Promotion of colorectal cancer by transcription factor BHLHE40 involves upregulation of ADAM19 and KLF7
Yuan Sui, Hanlin Jiang, Collyn M. Kellogg, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 19
Yuan Sui, Hanlin Jiang, Collyn M. Kellogg, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 19
Recent Advances in the Anticancer Applications of Benzimidazole Derivatives
Mohammad Mavvaji, Senem Akkoç
ChemistrySelect (2023) Vol. 8, Iss. 35
Closed Access | Times Cited: 17
Mohammad Mavvaji, Senem Akkoç
ChemistrySelect (2023) Vol. 8, Iss. 35
Closed Access | Times Cited: 17
Developments and future prospects of personalized medicine in head and neck squamous cell carcinoma diagnoses and treatments
Shalindu Malshan Jayawickrama, Piyumi Madhushani Ranaweera, Roshan Pradeep, et al.
Cancer Reports (2024) Vol. 7, Iss. 3
Open Access | Times Cited: 8
Shalindu Malshan Jayawickrama, Piyumi Madhushani Ranaweera, Roshan Pradeep, et al.
Cancer Reports (2024) Vol. 7, Iss. 3
Open Access | Times Cited: 8
DNA methylation enables recurrent endogenization of giant viruses in an animal relative
Luke A. Sarre, Iana V. Kim, Vladimir Ovchinnikov, et al.
Science Advances (2024) Vol. 10, Iss. 28
Open Access | Times Cited: 7
Luke A. Sarre, Iana V. Kim, Vladimir Ovchinnikov, et al.
Science Advances (2024) Vol. 10, Iss. 28
Open Access | Times Cited: 7
DNA methylation enables recurrent endogenization of giant viruses in an animal relative
Luke A. Sarre, Iana V. Kim, Vladimir Ovchinnikov, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Luke A. Sarre, Iana V. Kim, Vladimir Ovchinnikov, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Resolving DNA Damage: Epigenetic Regulation of DNA Repair
Panagiotis Karakaidos, Dimitris Karagiannis, Θεόδωρος Ράμπιας
Molecules (2020) Vol. 25, Iss. 11, pp. 2496-2496
Open Access | Times Cited: 48
Panagiotis Karakaidos, Dimitris Karagiannis, Θεόδωρος Ράμπιας
Molecules (2020) Vol. 25, Iss. 11, pp. 2496-2496
Open Access | Times Cited: 48
Histone demethylase KDM4C controls tumorigenesis of glioblastoma by epigenetically regulating p53 and c-Myc
Dong Hoon Lee, Go Woon Kim, Jung Yoo, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 37
Dong Hoon Lee, Go Woon Kim, Jung Yoo, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 37
Targeting ferroptosis in osteosarcoma
Jiazheng Zhao, Yi Zhao, Xiaowei Ma, et al.
Journal of bone oncology (2021) Vol. 30, pp. 100380-100380
Open Access | Times Cited: 34
Jiazheng Zhao, Yi Zhao, Xiaowei Ma, et al.
Journal of bone oncology (2021) Vol. 30, pp. 100380-100380
Open Access | Times Cited: 34
The Diverse Roles of Histone Demethylase KDM4B in Normal and Cancer Development and Progression
Zhongze Wang, Huarui Cai, Erhu Zhao, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 25
Zhongze Wang, Huarui Cai, Erhu Zhao, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 25
Targeting KDM4 for treating PAX3-FOXO1–driven alveolar rhabdomyosarcoma
Shivendra V. Singh, Ahmed Abu‐Zaid, Hongjian Jin, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 653
Open Access | Times Cited: 25
Shivendra V. Singh, Ahmed Abu‐Zaid, Hongjian Jin, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 653
Open Access | Times Cited: 25
Recent Advances with KDM4 Inhibitors and Potential Applications
Qiong Wu, Brandon Young, Yan Wang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 14, pp. 9564-9579
Open Access | Times Cited: 25
Qiong Wu, Brandon Young, Yan Wang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 14, pp. 9564-9579
Open Access | Times Cited: 25
Oxidized low-density lipoprotein regulates macrophage polarization in atherosclerosis
Yonghang He, Tingting Liu
International Immunopharmacology (2023) Vol. 120, pp. 110338-110338
Closed Access | Times Cited: 16
Yonghang He, Tingting Liu
International Immunopharmacology (2023) Vol. 120, pp. 110338-110338
Closed Access | Times Cited: 16
Targeting epigenetic regulation for cancer therapy using small molecule inhibitors
Amit Kumar, Luni Emdad, Paul B. Fisher, et al.
Advances in cancer research (2023), pp. 73-161
Closed Access | Times Cited: 15
Amit Kumar, Luni Emdad, Paul B. Fisher, et al.
Advances in cancer research (2023), pp. 73-161
Closed Access | Times Cited: 15
BACH1 encourages ferroptosis by activating KDM4C‐mediated COX2 demethylation after cerebral ischemia–reperfusion injury
Tianqi Zhang, Meimei Yang, Chi Ma, et al.
European Journal of Neuroscience (2023) Vol. 58, Iss. 1, pp. 2194-2214
Closed Access | Times Cited: 15
Tianqi Zhang, Meimei Yang, Chi Ma, et al.
European Journal of Neuroscience (2023) Vol. 58, Iss. 1, pp. 2194-2214
Closed Access | Times Cited: 15
Emerging role of FBXO22 in carcinogenesis
Jiangting Cheng, Min Lin, Man Chu, et al.
Cell Death Discovery (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 37
Jiangting Cheng, Min Lin, Man Chu, et al.
Cell Death Discovery (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 37
Histone Methylases and Demethylases Regulating Antagonistic Methyl Marks: Changes Occurring in Cancer
Joyce Taylor‐Papadimitriou, Joy Burchell
Cells (2022) Vol. 11, Iss. 7, pp. 1113-1113
Open Access | Times Cited: 22
Joyce Taylor‐Papadimitriou, Joy Burchell
Cells (2022) Vol. 11, Iss. 7, pp. 1113-1113
Open Access | Times Cited: 22
